Primary peritoneal carcinoma: a treatable subset of patients with adenocarcinoma of unknown primary

Aust N Z J Surg. 1996 Feb;66(2):124-5. doi: 10.1111/j.1445-2197.1996.tb01133.x.

Abstract

The syndrome of adenocarcinoma of unknown primary (ACUP) is a frequent problem in both medical and surgical practice. The prognosis is poor, the median lifespan being 4 months. In general, multiple invasive procedures aimed at determining the primary tumour are not warranted due to the low frequency of detecting a tumour for which adequate treatment exists. In this paper we wish to highlight a subset of female patients presenting with malignant ascites and no evidence of a pelvic mass, who on laparotomy were found to have primary peritoneal papillary serous adenocarcinoma. These tumours must be regarded as a potentially treatable subset of patients with ACUP in view of their frequent response to chemotherapy and relatively good prognosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Cystadenocarcinoma, Papillary / diagnosis
  • Cystadenocarcinoma, Papillary / drug therapy*
  • Cystadenocarcinoma, Papillary / mortality
  • Disease-Free Survival
  • Female
  • Humans
  • Middle Aged
  • Peritoneal Neoplasms / diagnosis
  • Peritoneal Neoplasms / drug therapy*
  • Peritoneal Neoplasms / mortality
  • Prognosis
  • Time Factors

Substances

  • Cyclophosphamide
  • Carboplatin